| Literature DB >> 29339754 |
Shulin Fu1,2, Huashan Liu1, Lei Xu1, Yinsheng Qiu3,4, Yu Liu1,2, Zhongyuan Wu1,2, Chun Ye1,2, Yongqing Hou1,2, Chien-An Andy Hu1,5.
Abstract
Haemophilus parasuis (H. parasuis) can cause vascular inflammatory injury, but the molecular basis of this effect remains unclear. In this study,we investigated the effect of the anti-inflammatory, anti-microbial and anti-oxidant agent, baicalin, on the nuclear factor (NF)-κB and NLRP3 inflammasome signaling pathway in pig primary aortic vascular endothelial cells. Activation of the NF-κB and NLRP3 inflammasome signaling pathway was induced in H. parasuis-infected cells. However, baicalin reduced the production of reactive oxygen species, apoptosis, and activation of the NF-κB and NLRP3 inflammasome signaling pathway in infected cells. These results revealed that baicalin can inhibit H. parasuis-induced inflammatory responses in porcine aortic vascular endothelial cells, and may thus offer a novel strategy for controlling and treating H. parasuis infection. Furthermore, the results suggest that piglet primary aortic vascular endothelial cells may provide an experimental model for future studies of H. parasuis infection.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29339754 PMCID: PMC5770393 DOI: 10.1038/s41598-018-19293-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Effect of baicalin on PAVECs viability in vitro. Cells viability was measured by CCK-8 assay. The data was expressed as mean ± SD of triplicate samples form at least three independent experiments. #P < 0.05 vs. control. ##P < 0.01 vs. control.
Figure 2Establishment of H. parasuis infection model using PAVECs. The release of TNF-α, IL-1β and IL-18 was determined to explore the MOI and optimal interaction time. *Indicates significance at P < 0.05.
Figure 3Effect of baicalin on release of proinflammatory cytokines triggered by H. parasuis in PAVECs. PAVECs were pre-treated with baicalin and co-cultured with H. parasuis. The release of proinflammatory cytokines in the cell culture supernatants was measured by ELISA assays. ##P < 0.01 vs. control. *Indicates significance at P < 0.05 and **indicates significance at P < 0.01.
Figure 4Effect of baicalin on proinflammatory cytokines expression triggered by H. parasuis in PAVECs. PAVECs were pre-treated with baicalin and incubated with H. parasuis. The expression of proinflammatory cytokines in the PAVECs were determined by qRT-PCR. ##P < 0.01 vs. control. *Indicates significance at P < 0.05 and **indicates significance at P < 0.01.
Figure 5Effect of baicalin on H. parasuis-induced ROS release in PAVECS. PAVECs were stained with DCFH-DA and DHE and the fluorescence intensities were determined using the fluorescence microplate reader. ##P < 0.01 vs. control. **Indicates significance at P < 0.01.
Figure 6Effect of baicalin on H. parasuis-induced cell apoptosis in PAVECS. PAVECs were labeled with FITC Annexin V/PI and detected by flow cytometry. ##P < 0.01 vs. control. **Indicates significance at P < 0.01.
Figure 7Effects of baicalin on activation of the NF-κB signaling pathway triggered by H. parasuis. (A) ELISA analysis of the levels of NF-κB p65 expression in the PAVECs. (B) Fluorescence observation of the levels of NF-κB p65 expression in the PAVECs. ##P < 0.01 vs. control. **Indicates significance at P < 0.01.
Figure 8Effects of baicalin on activation of the NLRP3 inflammasome signaling pathway triggered by H. parasuis. (A,B,C) qRT-PCR analysis of the levels of NLRP3 inflammasome (NLRP3, ASC and Caspase-1) expression in the PAVECs. (D) Detection of the levels of cleaved caspase-1 in the PAVECs. ##P < 0.01 vs. control. **Indicates significance at P < 0.01.
Primers for qRT-PCR.
| Gene | Nucleotide sequence (5′-3′) | Tm (°C) | Length (bp) |
|---|---|---|---|
| β-actin | Forward TGCGGGACATCAAGGAGAAG | 57.4 | 216 |
| Reverse AGTTGAAGGTGGTCTCGTGG | 57.4 | ||
| NLRP3 | Forward GGAGGAGGAGGAAGAGGAGATA | 59.5 | 147 |
| Reverse AGGACTGAGAAGATGCCACTAC | 57.7 | ||
| ASC | Forward ACAACAAACCAGCACTGCAC | 55.4 | 126 |
| Reverse CTGCCTGGTACTGCTCTTCC | 59.5 | ||
| Caspase-1 | Forward GAAGGAGAAGAGGAGGCTGTT | 57.6 | 268 |
| Reverse AGATTGTGAACCTGTGGAGAGT | 55.8 | ||
| IL-1β | Forward TCTGCATGAGCTTTGTGCAAG | 55.6 | 225 |
| Reverse ACAGGGCAGACTCGAATTCAAC | 57.7 | ||
| IL-18 | Forward AGTAACCATCTCTGTGCAGTGT | 55.8 | 155 |
| Reverse TCTTATCATCATGTCCAGGAAC | 53.9 | ||
| TNF-α | Forward CGCTCTTCTGCCTACTGCACTTC | 61.3 | 164 |
| Reverse CTGTCCCTCGGCTTTGACATT | 57.6 | ||
| IL-6 | Forward CCAGGAACCCAGCTATGAAC | 57.4 | 142 |
| Reverse CTGCACAGCCTCGACATT | 54.9 | ||
| IL-8 | Forward CAGAGCCAGGAAGAGACT | 54.9 | 461 |
| Reverse GACCAGCACAGGAATGAG | 54.9 | ||
| IL-10 | Forward GCATCCACTTCCAGGCCA | 57.2 | 176 |
| Reverse CTTCCTCATCTTCATCGTCA | 53.4 | ||
| COX-2 | Forward CTGTCCCATCCCTCGGTTTA | 54.4 | 105 |
| Reverse TCTCTGAGCACTGTCCGTAAT | 54.4 | ||
| NLRP1 | Forward AGAACCTCGCATAGTCATCA | 50.1 | 276 |
| Reverse CATCCTGGCTCATCTACAC | 50.2 | ||
| NLRC4 | Forward TTCTCCTTGATGGCTACAGTGA | 54.9 | 109 |
| Reverse TGTGGTGGCAGTAACATTGAC | 54.7 | ||
| AIM2 | Forward GTAGTCCAGAAGGTAACAGAA | 50.2 | 193 |
| Reverse TGCTATGAACTCCAGATGTC | 50.2 |